Evvy
Evvy offers a vaginal microbiome testing and care platform targeting conditions such as bacterial vaginosis (BV), yeast infections, aerobic vaginitis, and fertility-related concerns. The company provides at-home testing, clinician-reviewed results, and personalized treatment plans, including prescriptions when eligible.
Public-source profile · Company ownership not verified. Sources & corrections
The short feature · 2 min read
Evvy, at a glance
Built for · Women and individuals with vaginas experiencing recurrent or unexplained vaginal symptoms, fertility concerns, or seeking proactive vaginal health management…
Based on company material. Product claims are attributed to the company.
- 01
The problem
Traditional vaginal healthcare often relies on limited diagnostic methods, such as microscopy or culture-based tests, which may not capture the full spectrum of microbial imbalances. This can lead to misdiagnosis, ineffective treatments, or prolonged symptoms for conditions like BV, yeast infections, and unexplained vaginal discomfort.
Sources [1]
- 02
The product approach
Evvy’s platform uses metagenomic sequencing (mNGS) to test for over 700 bacteria and fungi from a single at-home swab. Results are reviewed by licensed clinicians and include personalized insights and treatment plans, such as prescriptions or probiotics, tailored to the user’s microbiome profile.
Sources [1]
- 03
What stands out
Unlike standard diagnostic methods, Evvy’s test provides a comprehensive analysis of the vaginal microbiome, including rare or understudied microbes. The platform also integrates clinician oversight and ongoing tracking for users with a membership, allowing them to monitor changes in their microbiome over time.
Sources [1]
What could be hard to replicate?
A useful product is not automatically a moat. These mechanisms need evidence of a lasting advantage.
Technology & IP
Company claimEvvy claims its test is the only clinical, validated mNGS vaginal health test, offering broader microbial detection than traditional methods. This could create a technological barrier for competitors seeking to replicate its diagnostic depth.
Mechanism → evidence check
What prevents another team from reproducing the capability?
Sources [1]
Switching costs
Company claimThe platform’s integration of clinician-reviewed results and prescription eligibility may establish a switching cost for users who rely on its personalized care plans, as alternative services may not offer comparable end-to-end support.
Mechanism → evidence check
What value would a customer lose when changing products?
Sources [1]
The question to watch
What evidence shows that customers choose this product over alternatives, and keep using it?
Explore the evidence · 1 source
- [1] Evvy company website
Company material · checked 5/10/2026
pioneering precision care for vaginal health Testing Care Tracking State-of-the-Art Testing Our at-home vaginal microbiome test is only clinical, validated mNGS vaginal health test —…
About
Get innovative vaginal healthcare, powered by our state-of-the-art Vaginal Microbiome Test. Our clinical care platform includes Rx for bacterial vaginosis (BV), yeast infections, aerobic vaginitis, fertility and more. Trusted by 100,000+ users.
Founders
- Priyanka Jain
- Pita Navarro
- Laine Bruzek
Profile sources, ownership & corrections
Company ownership is not verified
This profile was compiled from public sources and hasn't been verified by Evvy. Claim it to correct the details, add your team and funding history, and request review of your company information.
Compiled from news coverage, the company's own website.
Similar startups
Anees Health coordinates doctor home visits, nursing, physiotherapy, and lab tests for patients in Greater Cairo, Egypt.
Digital journaling tools aim to make self-reflection more accessible, but many lack interactive guidance or structured support.
VytalYou operates India’s first medically supervised preventive longevity clinic network.
OpenEvidence is a medical knowledge platform designed for healthcare professionals.